A computer program easily run on a tablet or a smartphone that compares a spot on a patient's skin to images of both benign and malignant lesions may be a useful, noninvasive tool for physicians when deciding when to do a ...
Oct 1, 2015
0
52
Newly identified mutations in a gene that makes cells immortal appear to play a pivotal role in three of the most common types of brain tumors, as well as cancers of the liver, tongue and urinary tract, according to research ...
Mar 18, 2013
0
0
Yale Cancer Center researchers have identified a gene in melanoma that can dramatically affect the growth of the disease. The findings, published in the journal Cell Reports, provide new insight into how melanoma grows and ...
Feb 29, 2016
0
173
Many melanoma patients are treated with drugs called BRAF or MEK inhibitors that specifically target the mutant proteins created in cancerous tumors. These inhibitors can block the tumors' ability to grow and spread.
Feb 28, 2022
0
52
Can a very common allergy medicine improve survival among patients suffering from the serious skin cancer, malignant melanoma? A new study from Lund University in Sweden indicates that this may be the case.
May 11, 2020
0
19
A new study of more than 1,000 primary care melanoma screenings in the western Pennsylvania area in 2014 suggests that overall the practice complies with the old medical maxim to "first do no harm." The numbers show that ...
Jul 8, 2016
0
117
(HealthDay)—Many people who've had melanoma skin cancer don't regularly check their skin for new or recurring signs of cancer, a new study reveals.
Oct 16, 2015
0
10
Indoor tanning beds can cause non-melanoma skin cancer – and the risk is greater the earlier one starts tanning, according to a new analysis led by UCSF.
Oct 2, 2012
1
0
(HealthDay)—For patients with cutaneous melanoma, whites have the longest survival time, according to a study published in the November issue of the Journal of the American Academy of Dermatology.
Oct 29, 2016
0
1
An article published in Scientific Reports describes a study demonstrating the effectiveness of a peptide developed by Brazilian scientists, called Rb4, in combating cancer progression in an animal model, especially malignant ...
May 20, 2022
0
53
